Latest Insurance News

Beamtree Holdings appoints Marek Stepniak as CEO, signaling a strategic push in international markets with a strong leadership hand familiar with the company’s growth trajectory.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

Argo Investments reports a robust half-year profit of $121.2 million and announces a record fully franked interim dividend of 17.0 cents per share, driven by increased dividend revenue and strategic portfolio moves.

Bridge SaaS Limited has recorded its first cashflow positive quarter, driven by strong growth at Brightside and strategic moves into the NDIS and DES sectors. The company is advancing plans for a tailored NDIS 'lite' SaaS offering aimed at smaller providers.

Advanced Health Intelligence Ltd (AHI) has secured USD 4 million in convertible debt funding and launched two new commercial partnerships in Canada and the UK, marking significant progress despite its ongoing ASX trading suspension.

State Gas Limited reports successful progress in its High Density Natural Gas (HDNG) trials with large mine trucks and resolves a key access dispute, setting the stage for expanded operations and drilling programs in 2025.

Emyria Limited reports strong progress in its MDMA and psilocybin-assisted therapy programs alongside a successful $2.525 million capital raise, positioning the company for expanded mental health treatment services.

North Stawell Minerals Ltd reported a strong cash position with a $1 million increase in cash reserves for the December quarter, preparing for intensified exploration activities.

Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.

Credit Clear Limited has reported a robust first half of FY25 with record revenue and a significant rise in profitability, reaffirming its full-year guidance amid strong client acquisition.

Lumos Diagnostics reported a robust Q2 FY25 with a 71% revenue increase to US$2.9 million, driven by strong product and service sales, alongside a strategic US$3 million BARDA partnership to advance its FebriDx test.

Control Bionics has delivered its strongest US sales quarter in years, nearing US$1 million in revenue, while broadening its market footprint with new commercial agreements and cost optimizations.